These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 31809217)
81. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care. Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351 [No Abstract] [Full Text] [Related]
82. A 2019 evaluation of opioid use disorder treatment resources in rural Utah counties. Ragsdale RJ; Nickman NA; Slager S; Fox ER J Am Pharm Assoc (2003); 2021; 61(5):513-521. PubMed ID: 33933362 [TBL] [Abstract][Full Text] [Related]
83. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder. Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182 [TBL] [Abstract][Full Text] [Related]
84. Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Hall NY; Le L; Majmudar I; Mihalopoulos C Drug Alcohol Depend; 2021 Apr; 221():108651. PubMed ID: 33667783 [TBL] [Abstract][Full Text] [Related]
85. The Challenges of the Health Care Providers in Refugee Settings: A Systematic Review. Kavukcu N; Altıntaş KH Prehosp Disaster Med; 2019 Apr; 34(2):188-196. PubMed ID: 30968818 [TBL] [Abstract][Full Text] [Related]
86. Rural Veterans Less Likely to Get Medication for Opioid Use Disorder. Rubin R JAMA; 2020 Jan; 323(4):300. PubMed ID: 31990300 [No Abstract] [Full Text] [Related]
87. Access to specialty healthcare in urban versus rural US populations: a systematic literature review. Cyr ME; Etchin AG; Guthrie BJ; Benneyan JC BMC Health Serv Res; 2019 Dec; 19(1):974. PubMed ID: 31852493 [TBL] [Abstract][Full Text] [Related]
88. Expanding access to buprenorphine treatment in rural areas with the use of telemedicine. Weintraub E; Greenblatt AD; Chang J; Himelhoch S; Welsh C Am J Addict; 2018 Dec; 27(8):612-617. PubMed ID: 30265425 [TBL] [Abstract][Full Text] [Related]
89. Rural-Urban Differences in Access to Primary Care: Beyond the Usual Source of Care Provider. Kirby JB; Yabroff KR Am J Prev Med; 2020 Jan; 58(1):89-96. PubMed ID: 31862103 [TBL] [Abstract][Full Text] [Related]
90. Provider-directed marketing may increase prescribing of medications for opioid use disorder. Nguyen T; Andraka-Christou B; Simon K; Bradford WD J Subst Abuse Treat; 2019 Sep; 104():104-115. PubMed ID: 31370974 [TBL] [Abstract][Full Text] [Related]
91. Optimizing endometrial cancer follow-up and survivorship care for rural and other underserved women: Patient and provider perspectives. Rutledge TL; Kano M; Guest D; Sussman A; Kinney AY Gynecol Oncol; 2017 May; 145(2):334-339. PubMed ID: 28325583 [TBL] [Abstract][Full Text] [Related]
92. Rural physical activity interventions in the United States: a systematic review and RE-AIM evaluation. Bhuiyan N; Singh P; Harden SM; Mama SK Int J Behav Nutr Phys Act; 2019 Dec; 16(1):140. PubMed ID: 31882013 [TBL] [Abstract][Full Text] [Related]
93. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Rosenblatt RA; Andrilla CH; Catlin M; Larson EH Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888 [TBL] [Abstract][Full Text] [Related]
94. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes. Hagedorn HJ; Wisdom JP; Gerould H; Pinsker E; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Harris AHS Addict Sci Clin Pract; 2019 Jul; 14(1):24. PubMed ID: 31291996 [TBL] [Abstract][Full Text] [Related]
95. Facilitators and Barriers to Naloxone Kit Use Among Opioid-Dependent Patients Enrolled in Medication Assisted Therapy Clinics in North Carolina. Khatiwoda P; Proeschold-Bell RJ; Meade CS; Park LP; Proescholdbell S N C Med J; 2018; 79(3):149-155. PubMed ID: 29735615 [No Abstract] [Full Text] [Related]
96. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue. McElrath K; Joseph H Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615 [TBL] [Abstract][Full Text] [Related]
97. Rural Emergency Medical Service Providers Perceptions on the Causes of and Solutions to the Opioid Crisis: A Qualitative Assessment. Blue H; Dahly A; Chhen S; Lee J; Shadiow A; Van Deelen AG; Palombi LC J Prim Care Community Health; 2021; 12():2150132720987715. PubMed ID: 33430686 [TBL] [Abstract][Full Text] [Related]
98. Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States. Joudrey PJ; Chen K; Oldfield BJ; Biegacki E; Fiellin DA J Addict Med; 2023 Sep-Oct 01; 17(5):615-617. PubMed ID: 37788621 [TBL] [Abstract][Full Text] [Related]
99. A systematic review of stigma interventions for providers who treat patients with substance use disorders. Bielenberg J; Swisher G; Lembke A; Haug NA J Subst Abuse Treat; 2021 Dec; 131():108486. PubMed ID: 34217033 [TBL] [Abstract][Full Text] [Related]
100. Psychosocial challenges affecting patient-defined medication for opioid use disorder treatment outcomes in a low-income, underserved population: Application of the social-ecological framework. Kleinman MB; Anvari MS; Seitz-Brown CJ; Bradley VD; Tralka H; Felton JW; Belcher AM; Greenblatt AD; Magidson JF J Subst Use Addict Treat; 2023 Jun; 149():209046. PubMed ID: 37061189 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]